The clock is ticking for Iterum after FDA hands down CRL for Pfizer castoff antibiotic

The clock is ticking for Iterum after FDA hands down CRL for Pfizer castoff antibiotic

Source: 
Endpoints
snippet: 

The FDA has sent the tiny biotech a complete response letter for the antibiotic sulopenem, shutting down hopes at getting the oral medication across the finish line, the drugmaker revealed Monday.